# Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy

> **NCT05570591** · NA · RECRUITING · sponsor: **Nova Eye Medical Pty Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DEVICE:** 2RT subthreshold nanosecond laser - active
- **DEVICE:** 2RT subthreshold nanosecond laser - sham

## Key facts

- **NCT ID:** NCT05570591
- **Lead sponsor:** Nova Eye Medical Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-18
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570591, "Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05570591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*